Pharmaceutical Compound Overview
Efexor XR 37.5 mg Pfizer is a pharmaceutical preparation containing venlafaxine hydrochloride in extended-release formulation. Venlafaxine belongs to the serotonin-norepinephrine reuptake inhibitor (SNRI) class of compounds, developed by Wyeth and now manufactured by Pfizer. This pharmaceutical-grade preparation enables researchers at Stroid UK Shop to investigate dual neurotransmitter reuptake inhibition mechanisms in controlled laboratory environments. The extended-release matrix technology allows for sustained compound release profiles in dissolution studies and pharmacokinetic research models.
Laboratory Research Applications
Researchers examine venlafaxine preparations to study dual-action neurotransmitter reuptake inhibition mechanisms affecting both serotonin and norepinephrine transporters. The compound demonstrates dose-dependent selectivity, with lower concentrations primarily affecting serotonin reuptake and higher concentrations extending to norepinephrine systems in preclinical models. Scientists investigate the pharmaceutical formulation’s extended-release characteristics for understanding sustained drug delivery systems. Comparative studies with compounds from our venlafaxine research category enable comprehensive analysis of different pharmaceutical preparations. Research teams also examine metabolite formation, particularly O-desmethylvenlafaxine, in hepatic microsome studies. The preparation serves as a reference standard for pharmaceutical analysis and bioequivalence testing protocols. Investigators studying monoamine transporter binding affinities utilise this compound alongside other neurotransmitter modulators available in our SARMs collection and peptide research compounds for comprehensive neuropharmacological investigations.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Venlafaxine Hydrochloride |
| Strength | 37.5 mg per capsule |
| Formulation | Extended-Release Capsules |
| Manufacturer | Pfizer |
| CAS Number | 99300-78-4 (venlafaxine HCl) |
| Molecular Formula | C₁₇H₂₇NO₂·HCl |
| Molecular Weight | 313.87 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | SNRI mechanism studies, pharmaceutical analysis |
Research Compliance Notice
Efexor XR 37.5 mg Pfizer is supplied exclusively for in-vitro laboratory research purposes and pharmaceutical analysis studies. This pharmaceutical preparation is not intended for human consumption, clinical application, or therapeutic use outside authorised research facilities. Researchers must ensure appropriate laboratory protocols and safety measures when handling pharmaceutical compounds. All investigations must comply with institutional research guidelines and applicable regulations governing pharmaceutical research materials. Storage should maintain pharmaceutical integrity under controlled laboratory conditions as specified by the manufacturer’s recommendations.
